Within a the latest review, we documented the identification and also the characterization of a new atypical opioid receptor with unique unfavorable regulatory Houses in direction of opioid peptides.1 Our benefits confirmed that ACKR3/CXCR7, hitherto often known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is usually a wide-s